WO2002067894A3 - Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors - Google Patents

Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors Download PDF

Info

Publication number
WO2002067894A3
WO2002067894A3 PCT/IB2002/000587 IB0200587W WO02067894A3 WO 2002067894 A3 WO2002067894 A3 WO 2002067894A3 IB 0200587 W IB0200587 W IB 0200587W WO 02067894 A3 WO02067894 A3 WO 02067894A3
Authority
WO
WIPO (PCT)
Prior art keywords
cyclooxygenase
fast dissolving
enzyme inhibitors
dissolving tablets
tablets
Prior art date
Application number
PCT/IB2002/000587
Other languages
French (fr)
Other versions
WO2002067894A2 (en
Inventor
Deepak Murpani
Vinod Kumar Arora
Rajiv Malik
Original Assignee
Ranbaxy Lab Ltd
Deepak Murpani
Vinod Kumar Arora
Rajiv Malik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Deepak Murpani, Vinod Kumar Arora, Rajiv Malik filed Critical Ranbaxy Lab Ltd
Priority to EP02702595A priority Critical patent/EP1367994A2/en
Priority to AU2002236120A priority patent/AU2002236120A1/en
Priority to HU0400098A priority patent/HUP0400098A2/en
Priority to PL02363771A priority patent/PL363771A1/en
Priority to SK1180-2003A priority patent/SK11802003A3/en
Publication of WO2002067894A2 publication Critical patent/WO2002067894A2/en
Publication of WO2002067894A3 publication Critical patent/WO2002067894A3/en
Priority to IS6932A priority patent/IS6932A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to fast dissolving tablets for oral administration comprising a therapeutically effective amount of drug(s) that acts selectively as a cyclooxygenase-2 (COX-2) enzyme inhibitor, which disintegrate quickly in mouth. The tablets are particularly suitable for patients who have difficulty in swallowing.
PCT/IB2002/000587 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors WO2002067894A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP02702595A EP1367994A2 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
AU2002236120A AU2002236120A1 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
HU0400098A HUP0400098A2 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors and process for their preparation
PL02363771A PL363771A1 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
SK1180-2003A SK11802003A3 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
IS6932A IS6932A (en) 2001-02-27 2003-08-27 Highly soluble cyclooxygenase-3 enzyme inhibitor tablets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN189DE2001 2001-02-27
IN189/DEL/01 2001-02-27

Publications (2)

Publication Number Publication Date
WO2002067894A2 WO2002067894A2 (en) 2002-09-06
WO2002067894A3 true WO2002067894A3 (en) 2002-12-19

Family

ID=11097035

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/000587 WO2002067894A2 (en) 2001-02-27 2002-02-27 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors

Country Status (9)

Country Link
EP (1) EP1367994A2 (en)
AU (1) AU2002236120A1 (en)
CZ (1) CZ20032568A3 (en)
HU (1) HUP0400098A2 (en)
IS (1) IS6932A (en)
OA (1) OA12686A (en)
PL (1) PL363771A1 (en)
SK (1) SK11802003A3 (en)
WO (1) WO2002067894A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CN1638739A (en) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 Compound for treating assuetude disturbance
TR200301552A1 (en) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Novel oral pharmacological formulations of rofecoxib.
GB0724707D0 (en) * 2007-12-19 2008-01-30 Burke Michael H A process for the preparation of an orally administered unit dose tablet
US10350171B2 (en) 2017-07-06 2019-07-16 Dexcel Ltd. Celecoxib and amlodipine formulation and method of making the same
CN108653225B (en) * 2018-08-15 2021-01-08 湖北舒邦药业有限公司 Nimesulide preparation and preparation method thereof
CN112569178B (en) * 2020-12-29 2022-09-09 南京百泽医药科技有限公司 Preparation method of parecoxib pharmaceutical composition and application of parecoxib pharmaceutical composition as sublingual preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748628A2 (en) * 1995-06-13 1996-12-18 American Home Products Corporation Oral formulations of S(+)-Etodolac
EP0945134A1 (en) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG New galenic formulations of meloxicam for oral administration
WO2001085134A1 (en) * 2000-05-12 2001-11-15 Emcure Pharmaceuticals Ltd Pharmaceutical solid compositions and process for the production of mouth dissolving tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0748628A2 (en) * 1995-06-13 1996-12-18 American Home Products Corporation Oral formulations of S(+)-Etodolac
EP0945134A1 (en) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG New galenic formulations of meloxicam for oral administration
WO2001085134A1 (en) * 2000-05-12 2001-11-15 Emcure Pharmaceuticals Ltd Pharmaceutical solid compositions and process for the production of mouth dissolving tablets

Also Published As

Publication number Publication date
HUP0400098A2 (en) 2004-04-28
SK11802003A3 (en) 2004-06-08
CZ20032568A3 (en) 2004-04-14
PL363771A1 (en) 2004-11-29
EP1367994A2 (en) 2003-12-10
IS6932A (en) 2003-08-27
WO2002067894A2 (en) 2002-09-06
OA12686A (en) 2006-06-21
AU2002236120A1 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
WO2004112711A3 (en) Oral extended-release composition
MXPA03006476A (en) Pharmaceutical dosage forms of epothilones for oral administration.
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
WO2005065646A3 (en) Novel drug compositions and dosage forms
EP1893182B8 (en) Oral dosage forms comprising progesterone and method of making and using the same
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
WO2001056544A3 (en) Shell-and-core dosage form approaching zero-order drug release
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2001032183A3 (en) Pharmaceutical compositions comprising oxcarbazepine
NO20042596L (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
WO2001022791A8 (en) Controlled release compositions comprising nimesulide
AU2003270255A1 (en) Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
ATE454132T1 (en) TABLET THAT MELTS QUICKLY IN THE ORAL CAVITY
WO2008049657A3 (en) Use of (meth)acrylate copolymers in slow-release pharmaceutical forms for reducing the influence of ethanol on active ingredient release
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
IS7006A (en) Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds
WO2006097943A3 (en) Pharmaceutical compositions of amlodipine and benazepril
WO2004032866A3 (en) Therapeutic formulations
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
EA201001108A1 (en) TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING
WO2007144083A3 (en) Ache-nmda combination wafer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002702595

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11802003

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: PV2003-2568

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 2002702595

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2003-2568

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: PV2003-2568

Country of ref document: CZ

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002702595

Country of ref document: EP

Ref document number: JP